-Paul R Gorry Researcher Activity Profile

Research Author Detailed Information 

Paul R Gorry Publication Rate By Year

Paul R Gorry has published 2 paper(s) in 2006, 7 paper(s) in 2007, 2 paper(s) in 2008, for a total of 11 research publications in total.

Paul R Pr Gorry Author Information

LAST NAME: gorry

FIRST NAME: Paul R

INITIALS: pr

AFFILIATION:

Papers

Paul R Gorry's Publication Record

1. Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote. Year Published: 2007
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
2. The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia. Year Published: 2006
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
3. HIV-1 entry inhibitors: classes, applications and factors affecting potency. Year Published: 2006
Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Victoria, Australia.
4. CXCR4 or CCR5 tropism of human immunodeficiency virus type 1 isolates does not determine the immunological milieu in patients responding to antiretroviral therapy. Year Published: 2007
School of Surgery and Pathology, University of Western Australia, Perth, WA, Australia. pprice@cyllene.uwa.edu.au
5. Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo. Year Published: 2007
Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Victoria, Australia. gorry@burnet.edu.au.
6. Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo. Year Published: 2007
Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Victoria, Australia. gorry@burnet.edu.au
7. Replication-dependent pathogenicity of attenuated nef-deleted HIV-1 in vivo. Year Published: 2007
Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Victoria, Australia. gorry@burnet.edu.au
8. Replication-dependent pathogenicity of attenuated nef-deleted HIV-1 in vivo. Year Published: 2007
Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Victoria, Australia. gorry@burnet.edu.au
9. Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo. Year Published: 2007
Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Victoria, Australia. gorry@burnet.edu.au
10. Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS. Year Published: 2008
Macfarlane Burnet Institute for Medical Research & Public Health, Melbourne, Victoria, Australia. gorry@burnet.edu.au.
11. Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS. Year Published: 2008
Macfarlane Burnet Institute for Medical Research & Public Health, Melbourne, Victoria, Australia. Jasminka@burnet.edu.au